/DGNOF
DGNOF Stock - DIAGNOS Inc.
Healthcare|Medical - Healthcare Information ServicesOTC
$0.23+4.55%
+$0.01 (+4.55%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.76
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.25
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for DGNOF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.23 – $0.23
TARGET (TP)$0.26
STOP LOSS$0.21
RISK/REWARD1:1.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.24
52W High$0.29
52W Low$0.13
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $103,797 | $170,158 | $438,833 | $267,073 | $331,517 |
| Gross Profit | $-943,561 | $-837,940 | $-418,296 | $-347,530 | $-473,455 |
| Gross Margin | -909.0% | -492.4% | -95.3% | -130.1% | -142.8% |
| Operating Income | $-3,811,093 | $-2,590,707 | $-2,554,437 | $-2,019,144 | $-2,707,319 |
| Net Income | $-4,286,449 | $-3,120,582 | $-2,608,218 | $-2,051,303 | $-3,382,873 |
| Net Margin | -4129.6% | -1833.9% | -594.4% | -768.1% | -1020.4% |
| EPS | $-0.05 | $-0.04 | $-0.04 | $-0.03 | $-0.05 |
Company Overview
DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
DGNOFBeat Rate
0%
Last 10 quarters
Avg Surprise
-25.1%
EPS vs Estimate
Beats / Misses
0/8
2 met exactly
Latest EPS
$-0.01
Q4 2025
EPS Surprise History
Q1 24
-32.6%
$-0.01vs$-0.01
Q2 24
-7.7%
$-0.01vs$-0.01
Q3 24
-26.6%
$-0.01vs$-0.01
Q4 24
-35.3%
$-0.01vs$-0.01
Q1 25
-43.9%
$-0.01vs$-0.01
Q2 25
-43.9%
$-0.01vs$-0.01
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 26, 2026 | — | — | — | — |
Q4 2025 | Dec 22, 2025 | — | — | — | — |
Q4 2025 | Nov 20, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 20, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 28, 2025 | $-0.01 | $-0.01 | -43.9% | ✗ MISS |
Q1 2025 | Feb 12, 2025 | $-0.01 | $-0.01 | -43.9% | ✗ MISS |
Q4 2024 | Nov 21, 2024 | $-0.01 | $-0.01 | -35.3% | ✗ MISS |
Q3 2024 | Jul 17, 2024 | $-0.01 | $-0.01 | -26.6% | ✗ MISS |
Q2 2024 | Apr 11, 2024 | $-0.01 | $-0.01 | -7.7% | ✗ MISS |
Q1 2024 | Feb 28, 2024 | $-0.01 | $-0.01 | -32.6% | ✗ MISS |
Q4 2023 | Nov 28, 2023 | $-0.01 | $-0.01 | -35.9% | ✗ MISS |
Q3 2023 | Aug 24, 2023 | — | $-0.01 | — | — |
Q3 2023 | Jul 13, 2023 | — | $-0.01 | — | — |
Q1 2023 | Jan 25, 2023 | — | $-0.01 | — | — |
Q4 2022 | Nov 29, 2022 | — | $-0.01 | — | — |
Q3 2022 | Aug 25, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q3 2022 | Jul 13, 2022 | $-0.01 | $-0.01 | -25.2% | ✗ MISS |
Q1 2022 | Feb 28, 2022 | $-0.01 | $-0.01 | 0.0% | = MET |
Q4 2021 | Oct 27, 2021 | — | $-0.01 | — | — |
Q3 2021 | Aug 10, 2021 | — | $-0.01 | — | — |
Latest News
Loading news...
Frequently Asked Questions about DGNOF
What is DGNOF's current stock price?
DIAGNOS Inc. (DGNOF) is currently trading at $0.23 per share. The stock has moved +4.55% today.
What is the analyst price target for DGNOF?
No analyst price targets are currently available for this stock.
What sector is DIAGNOS Inc. in?
DIAGNOS Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.
What is DGNOF's market cap?
DIAGNOS Inc. has a market capitalization of $0.02 billion, making it a small-cap company.
Does DGNOF pay dividends?
No, DIAGNOS Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHGIF
Alternate Health Corp.
$0.00
Mkt Cap: $0.0B
BBIXF
Bonus BioGroup Ltd.
$0.08
Mkt Cap: $0.1B
BMKDF
BioMark Diagnostics Inc.
$0.34
Mkt Cap: $0.0B
CLIFF
Cordlife Group Limited
$0.10
Mkt Cap: $0.0B
CLYYF
Celyad Oncology S.A.
$0.18
Mkt Cap: $0.0B
CRVW
CareView Communications, Inc.
$0.02
Mkt Cap: $0.0B
IPDQF
ImpediMed Limited
$0.02
Mkt Cap: $0.0B
MRAI
Marpai, Inc.
$0.70
Mkt Cap: $0.0B
POSC
Positron Corporation
$1.55
Mkt Cap: $0.0B
SPHRF
Starpharma Holdings Limited
$0.25
Mkt Cap: $0.1B
Explore stocks similar to DGNOF for comparison